Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor: The SWAP (SWitching Anti Platelet)-3 Study

Trial Profile

Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor: The SWAP (SWitching Anti Platelet)-3 Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Prasugrel
  • Indications Acute coronary syndromes; Thrombosis
  • Focus Pharmacodynamics
  • Acronyms SWAP-3
  • Most Recent Events

    • 12 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 04 Mar 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
    • 14 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top